apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. ELIGARD 22.5MG INJECTION

  3. ELIGARD 22.5MG INJECTION Substitute

ELIGARD 22.5MG INJECTION Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

LEUPROLIDE-22.5MG

Uses:

Treatment of Prostate cancer, Breast cancer, Endometriosis, Precocious puberty.

Medicinal Benefits:

ELIGARD 22.5MG INJECTION contains Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. ELIGARD 22.5MG INJECTION is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Being an anti-neoplastic or anticancer agent, ELIGARD 22.5MG INJECTION works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. ELIGARD 22.5MG INJECTION reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helps in shrinking of endometriosis and breast cancer.

FAQs

ELIGARD 22.5MG INJECTION is used to treat prostate cancer in men, breast cancer & endometriosis in women and precocious puberty (early puberty) in children.

ELIGARD 22.5MG INJECTION contains Leuprolide, a synthetic hormone that helps reduce the testosterone and oestrogen hormones in men and women, respectively. This process of lowering hormone levels can decrease cancer cell's growth in prostate cancer in men and shrinks endometriosis in women.

Yes, ELIGARD 22.5MG INJECTION commonly affects the hair by making them thin which further causes loss of hair. However, it is not very common. Hair reduction possibly happens due to the estrogen lowering effect of ELIGARD 22.5MG INJECTION . These effects are not long-lasting and may return after some time. If it matters to you then inform your doctor for further advice.

ELIGARD 22.5MG INJECTION may cause impotence and affect fertility in men. It is advised to speak to your doctor if you plan to have a family in the future before starting ELIGARD 22.5MG INJECTION .

ELIGARD 22.5MG INJECTION should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, regular monitoring of blood sugar levels is recommended while taking ELIGARD 22.5MG INJECTION and inform your doctor if you have diabetes before taking ELIGARD 22.5MG INJECTION .

ELIGARD 22.5MG INJECTION may worsen your mood disorders like depression. Hence it is advised to use ELIGARD 22.5MG INJECTION only when you are free from any kind of mental problems. Please consult your doctor for more information.

ELIGARD 22.5MG INJECTION is not recommended for patients suffering from heart rhythm problems such as arrhythmia (irregular heartbeat) as it may increase the risk of heart rhythm problems. Therefore, inform your doctor if you have any heart problems before taking ELIGARD 22.5MG INJECTION .

ELIGARD 22.5MG INJECTION may cause osteoporosis (bone thinning) due to the reduction of estrogen in the body. Regular bone density tests may help you monitor osteoporosis. Contact your doctor if you observe any sign of tendon pain or swelling while taking ELIGARD 22.5MG INJECTION .

Before starting treatment with ELIGARD 22.5MG INJECTION , you should inform your doctor if you are allergic to any of its ingredients. Let your doctor know if you are pregnant or breastfeeding, as ELIGARD 22.5MG INJECTION could harm the unborn baby. ELIGARD 22.5MG INJECTION may also affect fertility in men, so discuss with your doctor if you plan to start a family in the future. Also, make sure to inform your doctor if you have a history of liver or kidney disease, heart disease, recent heart attack, depression, brain tumours, electrolyte imbalances, diabetes, seizures, weak bones, or high cholesterol levels.

No, ELIGARD 22.5MG INJECTION does not need to be refrigerated. It should be stored at room temperature, away from direct sunlight.

ELIGARD 22.5MG INJECTION is typically administered by a healthcare provider either under the skin (subcutaneously) or into a muscle (intramuscularly). Please do not self-administer ELIGARD 22.5MG INJECTION .

No, ELIGARD 22.5MG INJECTION is not a chemotherapy medicine. ELIGARD 22.5MG INJECTION is a hormonal medicine that belongs to the class of gonadotropin-releasing hormone (GnRH) agonists. It is a synthetic hormone that acts similarly to the GnRH hormone produced by the hypothalamus in the brain.

Yes, ELIGARD 22.5MG INJECTION can stop periods. It is used to treat endometriosis, a condition where tissue similar to the lining of the uterus (womb) grows outside the uterus and causes painful or irregular periods. ELIGARD 22.5MG INJECTION works by suppressing the production of hormones that regulate the menstrual cycle, which can create a temporary menopause-like state, stopping periods for a while.

Yes, ELIGARD 22.5MG INJECTION is a hormonal medicine that works by suppressing the production of reproductive hormones in females. Using ELIGARD 22.5MG INJECTION during pregnancy is not recommended, as it may harm the developing foetus (newborn baby). Its use should be avoided during pregnancy unless prescribed by your doctor.

Taking ELIGARD 22.5MG INJECTION may affect your bone health by lowering certain hormone levels (such as oestrogen or testosterone), which can lead to decreased bone mineral density over time. Please consult your doctor about the potential risks of using ELIGARD 22.5MG INJECTION and ask about steps you can take to help protect your bones.

ELIGARD 22.5MG INJECTION may increase blood sugar levels (hyperglycaemia) or make existing diabetes worse. It is important to monitor your blood sugar levels while using ELIGARD 22.5MG INJECTION and consult your doctor if you have any concerns before or during treatment.